{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:12:57Z","timestamp":1763640777330,"version":"3.41.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1023\/a:1023485519485","type":"journal-article","created":{"date-parts":[[2003,6,6]],"date-time":"2003-06-06T13:42:07Z","timestamp":1054906927000},"page":"765-771","source":"Crossref","is-referenced-by-count":18,"title":["Differential Effect of Acute Hepatic Failure on in Vivo and in Vitro P-Glycoprotein Functions in the Intestine"],"prefix":"10.1007","volume":"20","author":[{"given":"Ryoko","family":"Yumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihisa","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"464400_CR1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1016086003070","volume":"13","author":"A. Tsuji","year":"1996","unstructured":"A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res.\n13:963-977 (1996).","journal-title":"Pharm. Res."},{"key":"464400_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-3659(99)00034-6","volume":"62","author":"L. Z. Benet","year":"1999","unstructured":"L. Z. Benet, T. Izumi, Y. Zhang, J. A. Silverman, and V. J. Wacher. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J. Control. Release\n62:25-31 (1999).","journal-title":"J. Control. Release"},{"key":"464400_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0009-9236(97)90027-8","volume":"62","author":"K. S. Lown","year":"1997","unstructured":"K. S. Lown, R. R. Mayo, A. B. Leichtman, H. L. Hsiao, D. K. P. Turgeon, P. Schmiedlin-Ren, M. B. Brown, W. Guo, S. J. Rossi, L. Z. Benet, and P. B. Watkins. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther.\n62:248-260 (1997).","journal-title":"Clin. Pharmacol. Ther."},{"key":"464400_CR4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mcp.2000.107912","volume":"68","author":"S. Masuda","year":"2000","unstructured":"S. Masuda, S. Uemoto, T. Hashida, Y. Inomata, K. Tanaka, and K. Inui. Effect of intestinal P-glycoprotein on daily tacrolimus trough level in a living-donor small bowel recipient. Clin. Pharmacol. Ther.\n68:98-103 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"464400_CR5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/mcp.2000.109797","volume":"68","author":"K. Westphal","year":"2000","unstructured":"K. Westphal, A. Weinbrenner, M. Zschiesche, G. Franke, M. Knoke, R. Oertel, P. Fritz, O. von Richter, R. Warzok, T. Hachenberg, H. M. Kauffmann, D. Schrenk, B. Terhaag, H. K. Kroemer, and W. Siegmund. Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug\/drug interaction. Clin. Pharmacol. Ther.\n68:345-355 (2000).","journal-title":"Clin. Pharmacol. Ther."},{"key":"464400_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","volume":"13","author":"V. J. Wacher","year":"1995","unstructured":"V. J. Wacher, C. Y. Wu, and L. Z. Benet. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer-chemotherapy. Mol. Carcinog.\n13:129-134 (1995).","journal-title":"Mol. Carcinog."},{"key":"464400_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3565(24)38117-0","volume":"289","author":"R. Yumoto","year":"1999","unstructured":"R. Yumoto, T. Murakami, R. Nakamoto, R. Hasegawa, J. Nagai, and M. Takano. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J. Pharmacol. Exp. Ther.\n289:149-155 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"464400_CR8","first-page":"145","volume":"29","author":"R. Yumoto","year":"2001","unstructured":"R. Yumoto, T. Murakami, M. Sanemasa, R. Nasu, J. Nagai, and M. Takano. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metab. Dispos.\n29:145-151 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"464400_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","volume":"104","author":"B. Greiner","year":"1999","unstructured":"B. Greiner, M. Eichelbaum, P. Fritz, H.-P. Kreichgauer, O. von Richter, J. Zundler, and H. K. Kroemer. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest.\n104:147-153 (1999).","journal-title":"J. Clin. Invest."},{"key":"464400_CR10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ndt\/16.8.1607","volume":"16","author":"C. Veau","year":"2001","unstructured":"C. Veau, C. Leroy, H. Banide, D. Auchere, S. Tardivel, R. Farinotti, and B. Lacour. Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion. Nephrol. Dial. Transplant\n16:1607-1614 (2001).","journal-title":"Nephrol. Dial. Transplant"},{"key":"464400_CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(25)09793-7","volume":"46","author":"J. S. Lee","year":"1994","unstructured":"J. S. Lee, K. Pauli, M. Alvarez, C. Hose, A. Monks, M. Grever, A. T. Fojo, and S. E. Bates. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol.\n46:627-638 (1994).","journal-title":"Mol. Pharmacol."},{"key":"464400_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1211\/0022357021771931","volume":"54","author":"H. Okabe","year":"2002","unstructured":"H. Okabe, I. Yano, Y. Hashimoto, H. Saito, and K. Inui. Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction. J. Pharm. Pharmacol.\n54:65-70 (2002).","journal-title":"J. Pharm. Pharmacol."},{"key":"464400_CR13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1211\/0022357011776036","volume":"53","author":"Z. H. Huang","year":"2001","unstructured":"Z. H. Huang, T. Murakami, A. Okochi, R. Yumoto, J. Nagai, and M. Takano. Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure. J. Pharm. Pharmacol.\n53:873-881 (2001).","journal-title":"J. Pharm. Pharmacol."},{"key":"464400_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0014-2999(00)00699-3","volume":"406","author":"Z. H. Huang","year":"2000","unstructured":"Z. H. Huang, T. Murakami, A. Okochi, R. Yumoto, J. Nagai, and M. Takano. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur. J. Pharmacol.\n406:453-460 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"464400_CR15","first-page":"102","volume":"57","author":"T. Murakami","year":"2002","unstructured":"T. Murakami, R. Yumoyo, J. Nagai, and M. Takano. Factors affecting the expression and function of P-glycoprotein in rats: drug treatments and diseased states. Pharmazie\n57:102-107 (2002).","journal-title":"Pharmazie"},{"key":"464400_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9440(10)65594-0","volume":"153","author":"J. Shi","year":"1998","unstructured":"J. Shi, K. Aisaki, Y. Ikawa, and K. Wake. Evidence of hepatocytes apoptosis in rat liver after the administration of carbon tetrachloride. Am. J. Pathol.\n153:515-525 (1998).","journal-title":"Am. J. Pathol."},{"key":"464400_CR17","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1177\/002215540004801004","volume":"48","author":"M. Yasuda","year":"2000","unstructured":"M. Yasuda, T. Okabe, J. Itoh, S. Takekoshi, H. Hasegawa, H. Nagata, R. Y. Osamura, and K. Watanabe. Differentiation of necrotic cell death with or without lysosomal activation: Application of acute liver injury models induced by carbon terachloride (CCl4) and dimethylnitrosamine (DMN). J. Histochem. Cytochem.\n48:1331-1339 (2000).","journal-title":"J. Histochem. Cytochem."},{"key":"464400_CR18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003088-199529050-00005","volume":"29","author":"D. J. Morgan","year":"1995","unstructured":"D. J. Morgan and A. J. McLean. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. Clin. Pharmacokinet.\n29:370-391 (1995).","journal-title":"Clin. Pharmacokinet."},{"key":"464400_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-199717010-00004","volume":"17","author":"J. F. Westphal","year":"1997","unstructured":"J. F. Westphal and J. M. Brogard. Drug administration in chronic liver disease. Drug Safety\n17:47-73 (1997).","journal-title":"Drug Safety"},{"key":"464400_CR20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1476-5381.1996.tb15550.x","volume":"118","author":"M. E. Cavet","year":"1996","unstructured":"M. E. Cavet, M. West, and N. L. Simmons. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol.\n118:1389-1396 (1996).","journal-title":"Br. J. Pharmacol."},{"key":"464400_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0016-5085(85)90507-4","volume":"88","author":"H. L. Bonkovsky","year":"1985","unstructured":"H. L. Bonkovsky, H. P. Hauri, U. Marti, R. Gasser, and U. A. Mayer. Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital. Gastroenterology\n88:458-467 (1985).","journal-title":"Gastroenterology"},{"key":"464400_CR22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"M. M. Bradford","year":"1976","unstructured":"M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.\n72:248-254 (1976).","journal-title":"Anal. Biochem."},{"key":"464400_CR23","first-page":"729","volume-title":"Textbook of Therapeutics Drug and Disease Management","author":"P. E. Nolan","year":"1996","unstructured":"P. E. Nolan Jr. C. l. Raehl, and D. G. Zarembski. Congestive heart failure. In E. T. Herfindal, and D. R. Gourley (eds.). Textbook of Therapeutics Drug and Disease Management, Williams & Wilkins, Baltimore, Maryland, 1996 pp. 729-761."},{"key":"464400_CR24","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1073\/pnas.94.19.10346","volume":"94","author":"B. No\u00e9","year":"1997","unstructured":"B. No\u00e9, B. Hagenbuchi, B. Stieger, and P. J. Meier. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc. Natl. Acad. Sci. USA\n94:10346-10350 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"464400_CR25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/dmd.30.2.220","volume":"30","author":"D. Sugiyama","year":"2002","unstructured":"D. Sugiyama, H. Kusuhara, Y. Shitara, T. Abe, and Y. Sugiyama. Effect of 17\u03b2-estradiol-D-17\u03b2-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates. Drug Metab. Dispos.\n30:220-223 (2002).","journal-title":"Drug Metab. Dispos."},{"key":"464400_CR26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1016184211491","volume":"19","author":"T. Kodawara","year":"2002","unstructured":"T. Kodawara, S. Masuda, H. Wakasugi, Y. Uwai, T. Futami, H. Saito, T. Abe, and K. Inui. Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver. Pharm. Res.\n19:738-743 (2002).","journal-title":"Pharm. Res."},{"key":"464400_CR27","doi-asserted-by":"crossref","first-page":"G1188","DOI":"10.1152\/ajpgi.2000.279.6.G1188","volume":"279","author":"H. C. Walters","year":"2000","unstructured":"H. C. Walters, A. L. Craddock, H. Fusegawa, M. C. Willingham, and P. A. Dawson. Expression, transport properties, and chromosomal location of organic anion transporter subtype 3. Am. J. Physiol. Gastrointest. Liver Physiol.\n279:G1188-G1200 (2000).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"464400_CR28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.1840180528","volume":"18","author":"H. Nakatsukasa","year":"1993","unstructured":"H. Nakatsukasa, J. A. Silverman, T. W. Gant, R. P. Evarts, and S. S. Thorgeirsson. Expression of multidrug resistance genes in rat liver during generation and after carbon tetrachloride intoxication. Hepatology\n18:1202-1207 (1993).","journal-title":"Hepatology"},{"key":"464400_CR29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-2952(94)90099-X","volume":"48","author":"U. S. Rao","year":"1994","unstructured":"U. S. Rao, R. L. Fine, and G. A. Scarborough. Antiestrogenes and steroid hormones: substrates of the human P-glycoprotein. Biochem. Pharmacol.\n48:287-292 (1994).","journal-title":"Biochem. Pharmacol."},{"key":"464400_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2133\/dmpk.17.245","volume":"17","author":"T. Murakami","year":"2002","unstructured":"T. Murakami, T. Fukuda, R. Yumoto, J. Nagai, and M. Takano. Interaction of endogenous compounds in human and rat urine with P-glycoprotein. Drug Metabol. Pharmacokin.\n17:245-252 (2002).","journal-title":"Drug Metabol. Pharmacokin."},{"key":"464400_CR31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","volume":"13","author":"W. O. Bechstein","year":"2000","unstructured":"W. O. Bechstein. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl. Int.\n13:313-326 (2000).","journal-title":"Transpl. Int."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1023485519485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1023485519485\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1023485519485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:49:07Z","timestamp":1754038147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1023485519485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["464400"],"URL":"https:\/\/doi.org\/10.1023\/a:1023485519485","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}